- Home
- CNTA vs ASTH Comparison
CNTA vs ASTH Comparison
Compare CNTA & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- ASTH
- Stock Information
- Founded
- CNTA 2020
- ASTH 1994
- Country
- CNTA United Kingdom
- ASTH United States
- Employees
- CNTA N/A
- ASTH N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- ASTH Professional Services
- Sector
- CNTA Health Care
- ASTH Consumer Discretionary
- Exchange
- CNTA Nasdaq
- ASTH Nasdaq
- Market Cap
- CNTA 1.6B
- ASTH 1.7B
- IPO Year
- CNTA 2021
- ASTH N/A
- Fundamental
- Price
- CNTA $13.51
- ASTH $24.79
- Analyst Decision
- CNTA Strong Buy
- ASTH Strong Buy
- Analyst Count
- CNTA 11
- ASTH 8
- Target Price
- CNTA $27.00
- ASTH $53.29
- AVG Volume (30 Days)
- CNTA 730.3K
- ASTH 299.9K
- Earning Date
- CNTA 05-14-2025
- ASTH 05-08-2025
- Dividend Yield
- CNTA N/A
- ASTH N/A
- EPS Growth
- CNTA N/A
- ASTH N/A
- EPS
- CNTA N/A
- ASTH 0.73
- Revenue
- CNTA $15,000,000.00
- ASTH $2,250,574,000.00
- Revenue This Year
- CNTA N/A
- ASTH $35.85
- Revenue Next Year
- CNTA N/A
- ASTH $20.73
- P/E Ratio
- CNTA N/A
- ASTH $33.96
- Revenue Growth
- CNTA 118.88
- ASTH 54.81
- 52 Week Low
- CNTA $7.90
- ASTH $23.12
- 52 Week High
- CNTA $19.09
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- CNTA 56.37
- ASTH 33.69
- Support Level
- CNTA $12.11
- ASTH $24.22
- Resistance Level
- CNTA $13.23
- ASTH $25.38
- Average True Range (ATR)
- CNTA 0.73
- ASTH 1.44
- MACD
- CNTA 0.12
- ASTH -0.25
- Stochastic Oscillator
- CNTA 98.13
- ASTH 13.66
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.